These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25173913)

  • 1. Pleiotropic effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors in pulmonary diseases: a comprehensive review.
    Krishna RK; Issa O; Saha D; Macedo FY; Correal B; Santana O
    Pulm Pharmacol Ther; 2015 Feb; 30():134-40. PubMed ID: 25173913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pleiotropic effects and therapeutic potential of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in malignancies: a comprehensive review.
    Zeichner S; Mihos CG; Santana O
    J Cancer Res Ther; 2012; 8(2):176-83. PubMed ID: 22842358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pleiotropic effects and therapeutic potential of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in gastrointestinal tract disorders: a comprehensive review.
    Cortes-Bergoderi M; Pineda AM; Santana O
    J Gastrointestin Liver Dis; 2013 Jun; 22(2):199-204. PubMed ID: 23799219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms and clinical evidence of the pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in central nervous system disorders: a comprehensive review.
    Yanuck D; Mihos CG; Santana O
    Int J Neurosci; 2012 Nov; 122(11):619-29. PubMed ID: 22720798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in cardiovascular disease: a comprehensive review.
    Mihos CG; Salas MJ; Santana O
    Cardiol Rev; 2010; 18(6):298-304. PubMed ID: 20926939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in rheumatologic disorders: a comprehensive review.
    Mihos CG; Artola RT; Santana O
    Rheumatol Int; 2012 Feb; 32(2):287-94. PubMed ID: 21805349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular effects of statins, beyond lipid-lowering properties.
    Mihos CG; Pineda AM; Santana O
    Pharmacol Res; 2014 Oct; 88():12-9. PubMed ID: 24631782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One statin, two statins, three statins, more: similarities and differences of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
    Turkoski BB
    Orthop Nurs; 2011; 30(1):62-5; quiz 66-7. PubMed ID: 21278557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermolecular differences of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors contribute to distinct pharmacologic and pleiotropic actions.
    Mason RP; Walter MF; Day CA; Jacob RF
    Am J Cardiol; 2005 Sep; 96(5A):11F-23F. PubMed ID: 16126019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of statins vs. non-statin lipid-lowering therapy on bone formation and bone mineral density biomarkers in patients with hyperlipidemia.
    Chuengsamarn S; Rattanamongkoulgul S; Suwanwalaikorn S; Wattanasirichaigoon S; Kaufman L
    Bone; 2010 Apr; 46(4):1011-5. PubMed ID: 20045497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Statins and their pleiotropic effects].
    Galus R; Zandecki Ł; Jóźwiak J; Włodarski K
    Pol Merkur Lekarski; 2008 Jun; 24(144):545-8. PubMed ID: 18702340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Pleiotropic Effects of Statins in Endocrine Disorders.
    De La Cruz JA; Mihos CG; Horvath SA; Santana O
    Endocr Metab Immune Disord Drug Targets; 2019; 19(6):787-793. PubMed ID: 30924424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinically relevant pleiotropic effects of statins: drug properties or effects of profound cholesterol reduction?
    Comparato C; Altana C; Bellosta S; Baetta R; Paoletti R; Corsini A
    Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):328-43. PubMed ID: 11887430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Statins and asthma].
    Pawlak J; Ziętkowski Z; Bodzenta-Łukaszyk A
    Postepy Hig Med Dosw (Online); 2011 Mar; 65():177-89. PubMed ID: 21502694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of sphingosine-1-phosphate signalling as a potential underlying mechanism of the pleiotropic effects of statin therapy.
    Egom EE; Rose RA; Neyses L; Soran H; Cleland JG; Mamas MA
    Crit Rev Clin Lab Sci; 2013; 50(3):79-89. PubMed ID: 23885725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMG-CoA reductase inhibition: anti-inflammatory effects beyond lipid lowering?
    März W; Köenig W
    J Cardiovasc Risk; 2003 Jun; 10(3):169-79. PubMed ID: 12775949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pleiotropic vascular protective effects of statins in perioperative medicine.
    Fang SY; Roan JN; Luo CY; Tsai YC; Lam CF
    Acta Anaesthesiol Taiwan; 2013 Sep; 51(3):120-6. PubMed ID: 24148741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin therapy: not just used to lower cholesterol?
    Kronmann L; Hatfield C; Kronmann K
    Crit Care Nurs Q; 2007; 30(2):154-60. PubMed ID: 17356356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory stress induces statin resistance by disrupting 3-hydroxy-3-methylglutaryl-CoA reductase feedback regulation.
    Chen Y; Ku H; Zhao L; Wheeler DC; Li LC; Li Q; Varghese Z; Moorhead JF; Powis SH; Huang A; Ruan XZ
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):365-76. PubMed ID: 24233489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Use of Statins in the Treatment and Prevention of Atrial Fibrillation.
    Groves D; Mihos CG; Larrauri-Reyes M; Santana O
    Cardiol Rev; 2016; 24(5):224-9. PubMed ID: 26401903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.